Intermittent fasting for obesity and related disorders: unveiling myths, facts, and presumptions
AUTOR(ES)
Halpern, Bruno; Mendes, Thiago Bosco
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
2021-02
RESUMO
ABSTRACT Intermittent fasting (IF) is an increasingly popular method of weight loss, as an alternative to daily caloric restriction (DCR). Several forms of IF exist, such as alternate-day fasting or time-restricted feeding regimens. Some of its proponents claim several health benefits unrelated to caloric restriction or weight loss, which rely mainly on animal models. Although several studies published in the last few years confirm that IF can be a useful and safe therapeutical option for obesity and related disorders, no superiority to conventional caloric restriction diets have emerged. There are still several questions left answered. In this Review, we discuss some of the claims, unveiling myths, facts, and presumptions about several models of IF. The focus of this article is obesity, but there is a brief discussion of the potential benefits of IF on overall human health.
Documentos Relacionados
- Genetic markers of osteoarticular disorders: facts and hopes
- Fluid therapy for children: facts, fashions and questions
- A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a perpetual dispute
- Re: A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ?perpetual dispute?
- Missing facts, different countries
